Previous 10 | Next 10 |
The stock price has been decimated after a sluggish commercial launch for Gimoti. COVID is not likely the only problem. The January funding will not be enough - Evoke will need to raise $20 mil to $60 mil to get to cash flow positive. The best outcome for current investors is prob...
Evoke Pharma (EVOK) announces the appointment of Vickie Reed to the company’s board of directors.The appointment follows the retirement of Ann Rhoads from the company's board after a tenure of more than eight years.Reed currently serves as Senior Vice President, Fin...
SOLANA BEACH, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced the appointment of Vickie Reed to the Company’s board of directors. After serving for...
Gainers: MultiPlan (MPLN) +17%, Trinity Biotech (TRIB) +15%, Acutus Medical (AFIB) +11%, Novan (NOVN) +8%, Salarius Pharmaceuticals (SLRX) +7%.Losers: Evoke Pharma (EVOK) -17%, Curis (CRIS) -16%, UroGen Pharma (URGN) -16%, Eargo (EAR...
Evoke Pharma, Inc. (EVOK) Q1 2021 Earnings Conference Call May 12, 2021, 16:30 ET Company Participants Christine Petraglia - The Ruth Group David Gonyer - Co-Founder, CEO, President & Director Christopher Quesenberry - Chief Commercial Officer, Gimoti Matthew D'Onofrio - Co-Founder, Chief...
Evoke Pharma (EVOK): Q1 GAAP EPS of -$0.08 misses by $0.01.Revenue of $0.09M misses by $0.18M.Shares -7.8%.Press Release For further details see: Evoke Pharma EPS misses by $0.01, misses on revenue
Nearly 293% growth of product sales, 235% growth of prescriptions and 87% increase in new prescribers for Gimoti ® New notice of allowance from USPTO to expand Gimoti patent estate SOLANA BEACH, Calif., May 12, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ...
SOLANA BEACH, Calif., May 05, 2021 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that the Company is scheduled to release its first quarter 2021 financial resu...
Gainers: Clover Health Investments (CLOV) +20%, Harrow Health (HROW) +12%, Brooklyn ImmunoTherapeutics (BTX) +8%, Evoke Pharma (EVOK) +8%, F-star Therapeutics (FSTX) +7%.Losers: Editas Medicine (EDIT) -15%, Timber Pharmaceuticals (TMBR) -...
Evoke Pharma (EVOK) announces that the United States Patent and Trademark Office ((USPTO)) issued a Notice of Allowance for U.S. Application No. 16/181,841 for Gimoti (metoclopramide) nasal spray.The patent will cover methods of use for nasal delivery of metoclopramide fo...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK)...